Need help finding what you are looking for?
Contact Us
PUBLISHER: Global Market Insights Inc. | PRODUCT CODE: 1132583
PUBLISHER: Global Market Insights Inc. | PRODUCT CODE: 1132583
Therapeutic Respiratory Devices Market Size By Product, By Application, By End-use, Industry Analysis Report, Regional Outlook, Growth Potential, Competitive Market Share & Forecast, 2022 - 2030
PUBLISHED:
PAGES: 330 Pages
DELIVERY TIME: 2-3 business days
SELECT AN OPTION
The global therapeutic respiratory devices market is anticipated to register considerable growth through 2030. The industry expansion can be attributed to the rising elderly population which is prone to respiratory problems due to weakened immune systems. To that end, the instances of respiratory-related infections have also risen, leading to lung cancer, COPD, and asthma. The high rate of respiratory deaths is likely to drive product sales in the projected timeline. Also, the availability of advanced medical devices to minimize the severity of every person's medical condition will foster market growth.
The high costs associated with the treatment of respiratory diseases may be a key factor hindering the industry expansion. As per a study, asthma results in approximately 500,000 deaths annually and over 1,300 deaths daily. Rising caseloads of respiratory diseases and increased intensity of illness have raised treatment costs. Eventually, it increases the burden on healthcare units due to direct and indirect expenses.
Based on product, the industry is segmented into positive airway pressure (PAP) devices, oxygen concentrators, ventilators, inhalers, humidifiers, and nebulizers. The ventilators segment registered over USD 4 billion in 2021, owing to technological advancements in product design and the surge in the geriatric population. Additionally, improved capabilities of ventilation technologies for lung injury prevention and fewer treatment times are likely to foster the growth of the segment.
On the basis of application, the industry is classified into COPD, asthma, obstructive sleep apnea, cystic fibrosis, and respiratory distress syndrome. The asthma segment held over 28% market share in 2021, owing to the introduction of advanced medications including inhalers and nebulizers. According to the data from the Asthma and Allergy Foundation of America, nearly 25 million people are susceptible to asthma in the U.S., which is equivalent to 1 in 13 people. Additionally, the average mortality from asthma is 11 in the U.S. daily. In 2020, 4,145 patients died of asthma, which increases the need for advanced asthma medications.
Based on end-use, the industry is categorized into hospitals, homecare settings, and emergency centers. The industry size from the homecare settings segment is flourishing at a considerable rate, owing to the adoption of improved treatment procedures that require minimal intervention from doctors. In addition, the increased psychological comfort and favorable environment facilitate the patient.
On the regional front, the industry is classified into North America, Europe, Asia Pacific, Latin America, and MEA. Latin America is expected to grow at over 4% CAGR, owing to the increased instances of respiratory problems in the region. Additionally, the adoption of the latest treatment modules for treating such ailments is likely to foster product sales in the region.
Product Code: 696
Table of Contents
Chapter 1 Methodology & Scope
- 1.1 Methodology
- 1.2 Market definitions
- 1.3 Forecast parameters
- 1.4 Data sources
- 1.4.1 Secondary
- 1.4.1.1 Paid sources
- 1.4.1.2 Unpaid sources
- 1.4.2 Primary
- 1.4.1 Secondary
Chapter 2 Executive Summary
- 2.1 Therapeutic respiratory devices industry 360 degree synopsis, 2017 - 2030
- 2.1.1 Business trends
- 2.1.2 Product trends
- 2.1.3 Application trends
- 2.1.4 End-use trends
- 2.1.5 Regional trends
Chapter 3 Therapeutic Respiratory Devices Industry Insights
- 3.1 Industry segmentation
- 3.2 Industry landscape, 2017 - 2030 (USD Million)
- 3.3 Industry impact forces
- 3.3.1 Growth drivers
- 3.3.1.1 Rising prevalence of respiratory diseases in developing countries
- 3.3.1.2 Increasing geriatric population globally
- 3.3.1.3 Technological innovation in developed countries
- 3.3.2 Industry pitfalls & challenges
- 3.3.2.1 Lack of patient compliance
- 3.3.2.2 Cost burden of respiratory diseases
- 3.3.1 Growth drivers
- 3.4 Growth potential analysis
- 3.4.1 By product
- 3.4.2 By application
- 3.4.3 By end-use
- 3.5 Technology landscape
- 3.6 Regulatory landscape
- 3.6.1 U.S.
- 3.6.2 Europe
- 3.7 COVID- 19 impact analysis
- 3.8 Porter's analysis
- 3.9 Competitive landscape, 2021
- 3.9.1 Company matrix analysis, 2021
- 3.10 PESTLE analysis
Chapter 4 Therapeutic Respiratory Devices Market, By Product
- 4.1 Key segment trends
- 4.2 Positive Airway Pressure (PAP) devices
- 4.2.1 Market size, by region, 2017 - 2030 (USD Million)
- 4.2.2 Continuous positive airway pressure (CPAP) devices
- 4.2.2.1 Market size, by region, 2017 - 2030 (USD Million)
- 4.2.3 Auto-titrating positive airway pressure (APAP) devices
- 4.2.3.1 Market size, by region, 2017 - 2030 (USD Million)
- 4.2.4 Bi-level positive airway pressure (BiPAP) devices
- 4.2.4.1 Market size, by region, 2017 - 2030 (USD Million)
- 4.3 Oxygen concentrators
- 4.3.1 Market size, by region, 2017 - 2030 (USD Million)
- 4.3.2 Fixed oxygen concentrators
- 4.3.2.1 Market size, by region, 2017 - 2030 (USD Million)
- 4.3.3 Portable oxygen concentrators
- 4.3.3.1 Market size, by region, 2017 - 2030 (USD Million)
- 4.4 Ventilators
- 4.4.1 Market size, by region, 2017 - 2030 (USD Million)
- 4.4.2 Adult ventilators
- 4.4.2.1 Market size, by region, 2017 - 2030 (USD Million)
- 4.4.3 Neonatal ventilators
- 4.4.3.1 Market size, by region, 2017 - 2030 (USD Million)
- 4.5 Inhalers
- 4.5.1 Market size, by region, 2017 - 2030 (USD Million)
- 4.5.2 Metered dose inhaler (MDI)
- 4.5.2.1 Market size, by region, 2017 - 2030 (USD Million)
- 4.5.3 Dry powder inhaler (DPI)
- 4.5.3.1 Market size, by region, 2017 - 2030 (USD Million)
- 4.5.4 Soft mist inhaler (SMI)
- 4.5.4.1 Market size, by region, 2017 - 2030 (USD Million)
- 4.6 Nebulizers
- 4.6.1 Market size, by region, 2017 - 2030 (USD Million)
- 4.6.2 Compressor-based nebulizers
- 4.6.2.1 Market size, by region, 2017 - 2030 (USD Million)
- 4.6.3 Piston-based hand-held nebulizers
- 4.6.3.1 Market size, by region, 2017 - 2030 (USD Million)
- 4.6.4 Ultrasonic nebulizers
- 4.6.4.1 Market size, by region, 2017 - 2030 (USD Million)
- 4.7 Humidifiers
- 4.7.1 Market size, by region, 2017 - 2030 (USD Million)
- 4.7.2 Heated humidifiers
- 4.7.2.1 Market size, by region, 2017 - 2030 (USD Million)
- 4.7.3 Passover humidifiers
- 4.7.3.1 Market size, by region, 2017 - 2030 (USD Million)
- 4.7.4 Integrated humidifiers
- 4.7.4.1 Market size, by region, 2017 - 2030 (USD Million)
- 4.7.5 Built-in humidifiers
- 4.7.5.1 Market size, by region, 2017 - 2030 (USD Million)
- 4.7.6 Standalone humidifiers
- 4.7.6.1 Market size, by region, 2017 - 2030 (USD Million)
- 4.8 Others
- 4.8.1 Market size, by region, 2017 - 2030 (USD Million)
Chapter 5 Therapeutic Respiratory Devices Market, By Application
- 5.1 Key segment trends
- 5.2 COPD
- 5.2.1 Market size, by region, 2017 - 2030 (USD Million)
- 5.3 Obstructive sleep apnea
- 5.3.1 Market size, by region, 2017 - 2030 (USD Million)
- 5.4 Asthma
- 5.4.1 Market size, by region, 2017 - 2030 (USD Million)
- 5.5 Respiratory distress syndrome
- 5.5.1 Market size, by region, 2017 - 2030 (USD Million)
- 5.6 Cystic fibrosis
- 5.6.1 Market size, by region, 2017 - 2030 (USD Million)
- 5.7 Others
- 5.7.1 Market size, by region, 2017 - 2030 (USD Million)
Chapter 6 Therapeutic Respiratory Devices Market, By End-use
- 6.1 Key segment trends
- 6.2 Hospitals
- 6.2.1 Market size, by region, 2017 - 2030 (USD Million)
- 6.3 Homecare settings
- 6.3.1 Market size, by region, 2017 - 2030 (USD Million)
- 6.4 Emergency centers
- 6.4.1 Market size, by region, 2017 - 2030 (USD Million)
Chapter 7 Therapeutic Respiratory Devices Market, By Region
- 7.1 Key regional trends
- 7.2 North America
- 7.2.1 Market size, by country, 2017 - 2030 (USD Million)
- 7.2.2 Market size, by product, 2017 - 2030 (USD Million)
- 7.2.2.1 Market size, by positive airway pressure (PAP) devices, 2017 - 2030 (USD Million)
- 7.2.2.2 Market size, by oxygen concentrators, 2017 - 2030 (USD Million)
- 7.2.2.3 Market size, by ventilators, 2017 - 2030 (USD Million)
- 7.2.2.4 Market size, by inhalers, 2017 - 2030 (USD Million)
- 7.2.2.5 Market size, by nebulizers, 2017 - 2030 (USD Million)
- 7.2.2.6 Market size, by humidifiers, 2017 - 2030 (USD Million)
- 7.2.3 Market size, by application, 2017 - 2030 (USD Million)
- 7.2.4 Market size, by end-use, 2017 - 2030 (USD Million)
- 7.2.5 U.S.
- 7.2.5.1 Market size, by product, 2017 - 2030 (USD Million)
- 7.2.5.1.1 Market size, by positive airway pressure (PAP) devices, 2017 - 2030 (USD Million)
- 7.2.5.1.2 Market size, by oxygen concentrators, 2017 - 2030 (USD Million)
- 7.2.5.1.3 Market size, by ventilators, 2017 - 2030 (USD Million)
- 7.2.5.1.4 Market size, by inhalers, 2017 - 2030 (USD Million)
- 7.2.5.1.5 Market size, by nebulizers, 2017 - 2030 (USD Million)
- 7.2.5.1.6 Market size, by humidifiers, 2017 - 2030 (USD Million)
- 7.2.5.2 Market size, by application, 2017 - 2030 (USD Million)
- 7.2.5.3 Market size, by end-use, 2017 - 2030 (USD Million)
- 7.2.5.1 Market size, by product, 2017 - 2030 (USD Million)
- 7.2.6 Canada
- 7.2.6.1 Market size, by product, 2017 - 2030 (USD Million)
- 7.2.6.1.1 Market size, by positive airway pressure (PAP) devices, 2017 - 2030 (USD Million)
- 7.2.6.1.2 Market size, by oxygen concentrators, 2017 - 2030 (USD Million)
- 7.2.6.1.3 Market size, by ventilators, 2017 - 2030 (USD Million)
- 7.2.6.1.4 Market size, by inhalers, 2017 - 2030 (USD Million)
- 7.2.6.1.5 Market size, by nebulizers, 2017 - 2030 (USD Million)
- 7.2.6.1.6 Market size, by humidifiers, 2017 - 2030 (USD Million)
- 7.2.6.2 Market size, by application, 2017 - 2030 (USD Million)
- 7.2.6.3 Market size, by end-use, 2017 - 2030 (USD Million)
- 7.2.6.1 Market size, by product, 2017 - 2030 (USD Million)
- 7.3 Europe
- 7.3.1 Market size, by country, 2017 - 2030 (USD Million)
- 7.3.2 Market size, by product, 2017 - 2030 (USD Million)
- 7.3.2.1 Market size, by positive airway pressure (PAP) devices, 2017 - 2030 (USD Million)
- 7.3.2.2 Market size, by oxygen concentrators, 2017 - 2030 (USD Million)
- 7.3.2.3 Market size, by ventilators, 2017 - 2030 (USD Million)
- 7.3.2.4 Market size, by inhalers, 2017 - 2030 (USD Million)
- 7.3.2.5 Market size, by nebulizers, 2017 - 2030 (USD Million)
- 7.3.2.6 Market size, by humidifiers, 2017 - 2030 (USD Million)
- 7.3.3 Market size, by application, 2017 - 2030 (USD Million)
- 7.3.4 Market size, by end-use, 2017 - 2030 (USD Million)
- 7.3.5 Germany
- 7.3.5.1 Market size, by product, 2017 - 2030 (USD Million)
- 7.3.5.1.1 Market size, by positive airway pressure (PAP) devices, 2017 - 2030 (USD Million)
- 7.3.5.1.2 Market size, by oxygen concentrators, 2017 - 2030 (USD Million)
- 7.3.5.1.3 Market size, by ventilators, 2017 - 2030 (USD Million)
- 7.3.5.1.4 Market size, by inhalers, 2017 - 2030 (USD Million)
- 7.3.5.1.5 Market size, by nebulizers, 2017 - 2030 (USD Million)
- 7.3.5.1.6 Market size, by humidifiers, 2017 - 2030 (USD Million)
- 7.3.5.2 Market size, by application, 2017 - 2030 (USD Million)
- 7.3.5.3 Market size, by end-use, 2017 - 2030 (USD Million)
- 7.3.5.1 Market size, by product, 2017 - 2030 (USD Million)
- 7.3.6 UK
- 7.3.6.1 Market size, by product, 2017 - 2030 (USD Million)
- 7.3.6.1.1 Market size, by positive airway pressure (PAP) devices, 2017 - 2030 (USD Million)
- 7.3.6.1.2 Market size, by oxygen concentrators, 2017 - 2030 (USD Million)
- 7.3.6.1.3 Market size, by ventilators, 2017 - 2030 (USD Million)
- 7.3.6.1.4 Market size, by inhalers, 2017 - 2030 (USD Million)
- 7.3.6.1.5 Market size, by nebulizers, 2017 - 2030 (USD Million)
- 7.3.6.1.6 Market size, by humidifiers, 2017 - 2030 (USD Million)
- 7.3.6.2 Market size, by application, 2017 - 2030 (USD Million)
- 7.3.6.3 Market size, by end-use, 2017 - 2030 (USD Million)
- 7.3.6.1 Market size, by product, 2017 - 2030 (USD Million)
- 7.3.7 France
- 7.3.7.1 Market size, by product, 2017 - 2030 (USD Million)
- 7.3.7.1.1 Market size, by positive airway pressure (PAP) devices, 2017 - 2030 (USD Million)
- 7.3.7.1.2 Market size, by oxygen concentrators, 2017 - 2030 (USD Million)
- 7.3.7.1.3 Market size, by ventilators, 2017 - 2030 (USD Million)
- 7.3.7.1.4 Market size, by inhalers, 2017 - 2030 (USD Million)
- 7.3.7.1.5 Market size, by nebulizers, 2017 - 2030 (USD Million)
- 7.3.7.1.6 Market size, by humidifiers, 2017 - 2030 (USD Million)
- 7.3.7.2 Market size, by application, 2017 - 2030 (USD Million)
- 7.3.7.3 Market size, by end-use, 2017 - 2030 (USD Million)
- 7.3.7.1 Market size, by product, 2017 - 2030 (USD Million)
- 7.3.8 Italy
- 7.3.8.1 Market size, by product, 2017 - 2030 (USD Million)
- 7.3.8.1.1 Market size, by positive airway pressure (PAP) devices, 2017 - 2030 (USD Million)
- 7.3.8.1.2 Market size, by oxygen concentrators, 2017 - 2030 (USD Million)
- 7.3.8.1.3 Market size, by ventilators, 2017 - 2030 (USD Million)
- 7.3.8.1.4 Market size, by inhalers, 2017 - 2030 (USD Million)
- 7.3.8.1.5 Market size, by nebulizers, 2017 - 2030 (USD Million)
- 7.3.8.1.6 Market size, by humidifiers, 2017 - 2030 (USD Million)
- 7.3.8.2 Market size, by application, 2017 - 2030 (USD Million)
- 7.3.8.3 Market size, by end-use, 2017 - 2030 (USD Million)
- 7.3.8.1 Market size, by product, 2017 - 2030 (USD Million)
- 7.3.9 Spain
- 7.3.9.1 Market size, by product, 2017 - 2030 (USD Million)
- 7.3.9.1.1 Market size, by positive airway pressure (PAP) devices, 2017 - 2030 (USD Million)
- 7.3.9.1.2 Market size, by oxygen concentrators, 2017 - 2030 (USD Million)
- 7.3.9.1.3 Market size, by ventilators, 2017 - 2030 (USD Million)
- 7.3.9.1.4 Market size, by inhalers, 2017 - 2030 (USD Million)
- 7.3.9.1.5 Market size, by nebulizers, 2017 - 2030 (USD Million)
- 7.3.9.1.6 Market size, by humidifiers, 2017 - 2030 (USD Million)
- 7.3.9.2 Market size, by application, 2017 - 2030 (USD Million)
- 7.3.9.3 Market size, by end-use, 2017 - 2030 (USD Million)
- 7.3.9.1 Market size, by product, 2017 - 2030 (USD Million)
- 7.4 Asia Pacific
- 7.4.1 Market size, by country, 2017 - 2030 (USD Million)
- 7.4.2 Market size, by product, 2017 - 2030 (USD Million)
- 7.4.2.1 Market size, by positive airway pressure (PAP) devices, 2017 - 2030 (USD Million)
- 7.4.2.2 Market size, by oxygen concentrators, 2017 - 2030 (USD Million)
- 7.4.2.3 Market size, by ventilators, 2017 - 2030 (USD Million)
- 7.4.2.4 Market size, by inhalers, 2017 - 2030 (USD Million)
- 7.4.2.5 Market size, by nebulizers, 2017 - 2030 (USD Million)
- 7.4.2.6 Market size, by humidifiers, 2017 - 2030 (USD Million)
- 7.4.3 Market size, by application, 2017 - 2030 (USD Million)
- 7.4.4 Market size, by end-use, 2017 - 2030 (USD Million)
- 7.4.5 China
- 7.4.5.1 Market size, by product, 2017 - 2030 (USD Million)
- 7.4.5.1.1 Market size, by positive airway pressure (PAP) devices, 2017 - 2030 (USD Million)
- 7.4.5.1.2 Market size, by oxygen concentrators, 2017 - 2030 (USD Million)
- 7.4.5.1.3 Market size, by ventilators, 2017 - 2030 (USD Million)
- 7.4.5.1.4 Market size, by inhalers, 2017 - 2030 (USD Million)
- 7.4.5.1.5 Market size, by nebulizers, 2017 - 2030 (USD Million)
- 7.4.5.1.6 Market size, by humidifiers, 2017 - 2030 (USD Million)
- 7.4.5.2 Market size, by application, 2017 - 2030 (USD Million)
- 7.4.5.3 Market size, by end-use, 2017 - 2030 (USD Million)
- 7.4.5.1 Market size, by product, 2017 - 2030 (USD Million)
- 7.4.6 Japan
- 7.4.6.1 Market size, by product, 2017 - 2030 (USD Million)
- 7.4.6.1.1 Market size, by positive airway pressure (PAP) devices, 2017 - 2030 (USD Million)
- 7.4.6.1.2 Market size, by oxygen concentrators, 2017 - 2030 (USD Million)
- 7.4.6.1.3 Market size, by ventilators, 2017 - 2030 (USD Million)
- 7.4.6.1.4 Market size, by inhalers, 2017 - 2030 (USD Million)
- 7.4.6.1.5 Market size, by nebulizers, 2017 - 2030 (USD Million)
- 7.4.6.1.6 Market size, by humidifiers, 2017 - 2030 (USD Million)
- 7.4.6.2 Market size, by application, 2017 - 2030 (USD Million)
- 7.4.6.3 Market size, by end-use, 2017 - 2030 (USD Million)
- 7.4.6.1 Market size, by product, 2017 - 2030 (USD Million)
- 7.4.7 India
- 7.4.7.1 Market size, by product, 2017 - 2030 (USD Million)
- 7.4.7.1.1 Market size, by positive airway pressure (PAP) devices, 2017 - 2030 (USD Million)
- 7.4.7.1.2 Market size, by oxygen concentrators, 2017 - 2030 (USD Million)
- 7.4.7.1.3 Market size, by ventilators, 2017 - 2030 (USD Million)
- 7.4.7.1.4 Market size, by inhalers, 2017 - 2030 (USD Million)
- 7.4.7.1.5 Market size, by nebulizers, 2017 - 2030 (USD Million)
- 7.4.7.1.6 Market size, by humidifiers, 2017 - 2030 (USD Million)
- 7.4.7.2 Market size, by application, 2017 - 2030 (USD Million)
- 7.4.7.3 Market size, by end-use, 2017 - 2030 (USD Million)
- 7.4.7.1 Market size, by product, 2017 - 2030 (USD Million)
- 7.4.8 Australia
- 7.4.8.1 Market size, by product, 2017 - 2030 (USD Million)
- 7.4.8.1.1 Market size, by positive airway pressure (PAP) devices, 2017 - 2030 (USD Million)
- 7.4.8.1.2 Market size, by oxygen concentrators, 2017 - 2030 (USD Million)
- 7.4.8.1.3 Market size, by ventilators, 2017 - 2030 (USD Million)
- 7.4.8.1.4 Market size, by inhalers, 2017 - 2030 (USD Million)
- 7.4.8.1.5 Market size, by nebulizers, 2017 - 2030 (USD Million)
- 7.4.8.1.6 Market size, by humidifiers, 2017 - 2030 (USD Million)
- 7.4.8.2 Market size, by application, 2017 - 2030 (USD Million)
- 7.4.8.3 Market size, by end-use, 2017 - 2030 (USD Million)
- 7.4.8.1 Market size, by product, 2017 - 2030 (USD Million)
- 7.4.9 South Korea
- 7.4.9.1 Market size, by product, 2017 - 2030 (USD Million)
- 7.4.9.1.1 Market size, by positive airway pressure (PAP) devices, 2017 - 2030 (USD Million)
- 7.4.9.1.2 Market size, by oxygen concentrators, 2017 - 2030 (USD Million)
- 7.4.9.1.3 Market size, by ventilators, 2017 - 2030 (USD Million)
- 7.4.9.1.4 Market size, by inhalers, 2017 - 2030 (USD Million)
- 7.4.9.1.5 Market size, by nebulizers, 2017 - 2030 (USD Million)
- 7.4.9.1.6 Market size, by humidifiers, 2017 - 2030 (USD Million)
- 7.4.9.2 Market size, by application, 2017 - 2030 (USD Million)
- 7.4.9.3 Market size, by end-use, 2017 - 2030 (USD Million)
- 7.4.9.1 Market size, by product, 2017 - 2030 (USD Million)
- 7.5 Latin America
- 7.5.1 Market size, by country, 2017 - 2030 (USD Million)
- 7.5.2 Market size, by product, 2017 - 2030 (USD Million)
- 7.5.2.1 Market size, by positive airway pressure (PAP) devices, 2017 - 2030 (USD Million)
- 7.5.2.2 Market size, by oxygen concentrators, 2017 - 2030 (USD Million)
- 7.5.2.3 Market size, by ventilators, 2017 - 2030 (USD Million)
- 7.5.2.4 Market size, by inhalers, 2017 - 2030 (USD Million)
- 7.5.2.5 Market size, by nebulizers, 2017 - 2030 (USD Million)
- 7.5.2.6 Market size, by humidifiers, 2017 - 2030 (USD Million)
- 7.5.3 Market size, by application, 2017 - 2030 (USD Million)
- 7.5.4 Market size, by end-use, 2017 - 2030 (USD Million)
- 7.5.5 Brazil
- 7.5.5.1 Market size, by product, 2017 - 2030 (USD Million)
- 7.5.5.1.1 Market size, by positive airway pressure (PAP) devices, 2017 - 2030 (USD Million)
- 7.5.5.1.2 Market size, by oxygen concentrators, 2017 - 2030 (USD Million)
- 7.5.5.1.3 Market size, by ventilators, 2017 - 2030 (USD Million)
- 7.5.5.1.4 Market size, by inhalers, 2017 - 2030 (USD Million)
- 7.5.5.1.5 Market size, by nebulizers, 2017 - 2030 (USD Million)
- 7.5.5.1.6 Market size, by humidifiers, 2017 - 2030 (USD Million)
- 7.5.5.2 Market size, by application, 2017 - 2030 (USD Million)
- 7.5.5.3 Market size, by end-use, 2017 - 2030 (USD Million)
- 7.5.5.1 Market size, by product, 2017 - 2030 (USD Million)
- 7.5.6 Mexico
- 7.5.6.1 Market size, by product, 2017 - 2030 (USD Million)
- 7.5.6.1.1 Market size, by positive airway pressure (PAP) devices, 2017 - 2030 (USD Million)
- 7.5.6.1.2 Market size, by oxygen concentrators, 2017 - 2030 (USD Million)
- 7.5.6.1.3 Market size, by ventilators, 2017 - 2030 (USD Million)
- 7.5.6.1.4 Market size, by inhalers, 2017 - 2030 (USD Million)
- 7.5.6.1.5 Market size, by nebulizers, 2017 - 2030 (USD Million)
- 7.5.6.1.6 Market size, by humidifiers, 2017 - 2030 (USD Million)
- 7.5.6.2 Market size, by application, 2017 - 2030 (USD Million)
- 7.5.6.3 Market size, by end-use, 2017 - 2030 (USD Million)
- 7.5.6.1 Market size, by product, 2017 - 2030 (USD Million)
- 7.5.7 Argentina
- 7.5.7.1 Market size, by product, 2017 - 2030 (USD Million)
- 7.5.7.1.1 Market size, by positive airway pressure (PAP) devices, 2017 - 2030 (USD Million)
- 7.5.7.1.2 Market size, by oxygen concentrators, 2017 - 2030 (USD Million)
- 7.5.7.1.3 Market size, by ventilators, 2017 - 2030 (USD Million)
- 7.5.7.1.4 Market size, by inhalers, 2017 - 2030 (USD Million)
- 7.5.7.1.5 Market size, by nebulizers, 2017 - 2030 (USD Million)
- 7.5.7.1.6 Market size, by humidifiers, 2017 - 2030 (USD Million)
- 7.5.7.2 Market size, by application, 2017 - 2030 (USD Million)
- 7.5.7.3 Market size, by end-use, 2017 - 2030 (USD Million)
- 7.5.7.1 Market size, by product, 2017 - 2030 (USD Million)
- 7.6 Middle East & Africa
- 7.6.1 Market size, by country, 2017 - 2030 (USD Million)
- 7.6.2 Market size, by product, 2017 - 2030 (USD Million)
- 7.6.2.1 Market size, by positive airway pressure (PAP) devices, 2017 - 2030 (USD Million)
- 7.6.2.2 Market size, by oxygen concentrators, 2017 - 2030 (USD Million)
- 7.6.2.3 Market size, by ventilators, 2017 - 2030 (USD Million)
- 7.6.2.4 Market size, by inhalers, 2017 - 2030 (USD Million)
- 7.6.2.5 Market size, by nebulizers, 2017 - 2030 (USD Million)
- 7.6.2.6 Market size, by humidifiers, 2017 - 2030 (USD Million)
- 7.6.3 Market size, by application, 2017 - 2030 (USD Million)
- 7.6.4 Market size, by end-use, 2017 - 2030 (USD Million)
- 7.6.5 South Africa
- 7.6.5.1 Market size, by product, 2017 - 2030 (USD Million)
- 7.6.5.1.1 Market size, by positive airway pressure (PAP) devices, 2017 - 2030 (USD Million)
- 7.6.5.1.2 Market size, by oxygen concentrators, 2017 - 2030 (USD Million)
- 7.6.5.1.3 Market size, by ventilators, 2017 - 2030 (USD Million)
- 7.6.5.1.4 Market size, by inhalers, 2017 - 2030 (USD Million)
- 7.6.5.1.5 Market size, by nebulizers, 2017 - 2030 (USD Million)
- 7.6.5.1.6 Market size, by humidifiers, 2017 - 2030 (USD Million)
- 7.6.5.2 Market size, by application, 2017 - 2030 (USD Million)
- 7.6.5.3 Market size, by end-use, 2017 - 2030 (USD Million)
- 7.6.5.1 Market size, by product, 2017 - 2030 (USD Million)
- 7.6.6 Saudi Arabia
- 7.6.6.1 Market size, by product, 2017 - 2030 (USD Million)
- 7.6.6.1.1 Market size, by positive airway pressure (PAP) devices, 2017 - 2030 (USD Million)
- 7.6.6.1.2 Market size, by oxygen concentrators, 2017 - 2030 (USD Million)
- 7.6.6.1.3 Market size, by ventilators, 2017 - 2030 (USD Million)
- 7.6.6.1.4 Market size, by inhalers, 2017 - 2030 (USD Million)
- 7.6.6.1.5 Market size, by nebulizers, 2017 - 2030 (USD Million)
- 7.6.6.1.6 Market size, by humidifiers, 2017 - 2030 (USD Million)
- 7.6.6.2 Market size, by application, 2017 - 2030 (USD Million)
- 7.6.6.3 Market size, by end-use, 2017 - 2030 (USD Million)
- 7.6.6.1 Market size, by product, 2017 - 2030 (USD Million)
- 7.6.7 UAE
- 7.6.7.1 Market size, by product, 2017 - 2030 (USD Million)
- 7.6.7.1.1 Market size, by positive airway pressure (PAP) devices, 2017 - 2030 (USD Million)
- 7.6.7.1.2 Market size, by oxygen concentrators, 2017 - 2030 (USD Million)
- 7.6.7.1.3 Market size, by ventilators, 2017 - 2030 (USD Million)
- 7.6.7.1.4 Market size, by inhalers, 2017 - 2030 (USD Million)
- 7.6.7.1.5 Market size, by nebulizers, 2017 - 2030 (USD Million)
- 7.6.7.1.6 Market size, by humidifiers, 2017 - 2030 (USD Million)
- 7.6.7.2 Market size, by application, 2017 - 2030 (USD Million)
- 7.6.7.3 Market size, by end-use, 2017 - 2030 (USD Million)
- 7.6.7.1 Market size, by product, 2017 - 2030 (USD Million)
Chapter 8 Company Profiles
- 8.1 Strategy dashboard, 2021
- 8.2 Breas Medical AB
- 8.2.1 Business overview
- 8.2.2 Financial data
- 8.2.3 Product landscape
- 8.2.4 Strategic outlook
- 8.2.5 Swot analysis
- 8.3 Dragerwerk AG & Co. KGaA
- 8.3.1 Business overview
- 8.3.2 Financial data
- 8.3.3 Product landscape
- 8.3.4 Strategic outlook
- 8.3.5 Swot analysis
- 8.4 Fisher & Paykel Healthcare Limited
- 8.4.1 Business overview
- 8.4.2 Financial data
- 8.4.3 Product landscape
- 8.4.4 Strategic outlook
- 8.4.5 Swot analysis
- 8.5 GE Healthcare
- 8.5.1 Business overview
- 8.5.2 Financial data
- 8.5.3 Product landscape
- 8.5.4 Strategic outlook
- 8.5.5 Swot analysis
- 8.6 Hamilton Medical
- 8.6.1 Business overview
- 8.6.2 Financial data
- 8.6.3 Product landscape
- 8.6.4 Strategic outlook
- 8.6.5 Swot analysis
- 8.7 Hill-Rom Services Inc. (Baxter)
- 8.7.1 Business overview
- 8.7.2 Financial data
- 8.7.3 Product landscape
- 8.7.4 Strategic outlook
- 8.7.5 Swot analysis
- 8.8 ICU Medical, Inc.
- 8.8.1 Business overview
- 8.8.2 Financial data
- 8.8.3 Product landscape
- 8.8.4 Strategic outlook
- 8.8.5 Swot analysis
- 8.9 Invacare Corporation
- 8.9.1 Business overview
- 8.9.2 Financial data
- 8.9.3 Product landscape
- 8.9.4 Strategic outlook
- 8.9.5 Swot analysis
- 8.10 Koninklijke Philips N.V.
- 8.10.1 Business overview
- 8.10.2 Financial data
- 8.10.3 Product landscape
- 8.10.4 Strategic outlook
- 8.10.5 Swot analysis
- 8.11 Medtronic
- 8.11.1 Business overview
- 8.11.2 Financial data
- 8.11.3 Product landscape
- 8.11.4 Strategic outlook
- 8.11.5 Swot analysis
- 8.12 ResMed
- 8.12.1 Business overview
- 8.12.2 Financial data
- 8.12.3 Product landscape
- 8.12.4 Strategic outlook
- 8.12.5 Swot analysis
- 8.13 Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
- 8.13.1 Business overview
- 8.13.2 Financial data
- 8.13.3 Product landscape
- 8.13.4 Strategic outlook
- 8.13.5 Swot analysis
- 8.14 VYAIRE MEDICAL, INC.
- 8.14.1 Business overview
- 8.14.2 Financial data
- 8.14.3 Product landscape
- 8.14.4 Strategic outlook
- 8.14.5 Swot analysis
Have a question?
SELECT AN OPTION
Have a question?
Questions? Please give us a call or visit the contact form.